[Treatment of differentiated carcinoma of the thyroid and its limitations].
The Authors report their experience in the management of differentiated thyroid cancer (DTC) with extrathyroidal extension including nodal and distant metastases. Twelve patients were included in the review: 11 of them were previously and elsewhere considered not curable. On the contrary, integrated treatment (surgery, radioiodine and radiation therapy) allowed to control the disease in 10 patients with a survival ranging from 14 years to 29 months. Cytopathologic analysis, in the two patients who died, showed a differentiated thyroid cancer with anaplastic areas. Integrated treatment, therefore, represents the treatment of choice for advanced DTC only in total absence of anaplastic cells.
Wiel Marin
A
A
Divisione di Chirurgia d'Urgenza, Università Cattolica del Sacro Cuore, Roma.
Carlucci
I
I
Wiel Marin
G
G
Massari
M
M
Romagnoli
A
A
D006801:Humans; D013964:Thyroid Neoplasms / Q000473:pathology / Q000601:surgery*